Boston Scientific Inc. (BSX): Today's Featured Health Care Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Boston Scientific ( BSX) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole was unchanged today. By the end of trading, Boston Scientific rose 12 cents (2.1%) to $5.52 on average volume. Throughout the day, 14.6 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 13.8 million shares. The stock ranged in a price between $5.34-$5.54 after having opened the day at $5.43 as compared to the previous trading day's close of $5.41. Other companies within the Health Care sector that increased today were: Hemispherx Biopharma ( HEB), up 20.5%, Neostem ( NBS), up 13.2%, Arrhythmia Research Technology ( HRT), up 12.4%, and TrovaGene ( TROV), up 10.9%.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $7.66 billion and is part of the health services industry. Shares are up 1.1% year to date as of the close of trading on Tuesday. Currently there are six analysts that rate Boston Scientific a buy, one analyst rates it a sell, and 15 rate it a hold.

TheStreet Ratings rates Boston Scientific as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and generally disappointing historical performance in the stock itself.

On the negative front, Biosante Pharmaceuticals ( BPAX), down 13.6%, American Caresource Holdings ( ANCI), down 13%, Tengion ( TNGN), down 12.2%, and Angeion Corporation ( ANGN), down 11.1%, were all laggards within the health care sector with Varian Medical Systems ( VAR) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.
null

If you liked this article you might like

Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways

Perils of Politics: Cramer's 'Mad Money' Recap (Monday 7/31/17)

These Stocks Are Ready to Reverse Course

Modi's Visit to Meet Trump Focuses Big Spotlight on the H-1B Visa Debate

Cramer: These Sectors Look Bullish (Part III)